ACO Name and Location
Georgia Physicians for Accountable Care, LLC
125 Plantation Centre Dr. S
Bldg 500, Ste A
Macon, Georgia 31210
ACO Primary Contact
Primary Contact Name |
Stephen Barry |
Primary Contact Phone Number |
(478) 254-9364 |
Primary Contact Email Address |
This email address is being protected from spambots. You need JavaScript enabled to view it. |
Organizational Information
ACO Participants:
ACO Participants |
ACO Participant in Joint Venture |
All Care Medical Associates, LLC |
N |
Ajay Kumar, MD, PC |
N |
Cornerstone Medical Assoc., LLC |
N |
Donald A Selph Jr MD, PC |
N |
Dr. Bolanle Sogade, M.D. LLC |
N |
Family Healthcare Connections, PC |
N |
Gastroenterology Associates of Central GA LLC |
N |
Ggd, Inc. |
N |
Heart of Georgia Primary Care, LLC |
N |
Lawrence Kirk, M.D. LLC |
N |
Lillette A. Intaphan MD, LLC |
N |
M Todd Peacock, M.D. P.C. |
N |
Magna Care Medical Specialists LLC |
N |
Margaret M. Nichols MD LLC |
N |
Rakesh Kumar, MD LLC |
N |
Robert Jones |
N |
Rutland Family Healthcare LLC |
N |
Smith-Lambert Clinic, P.C. |
N |
Southeast Georgia Pediatrics |
N |
The Corporation of Mercer University |
N |
ACO governing body:
Member |
Member's Voting Power |
Membership Type |
ACO Participant/TIN Legal Business Name/DBA, if Applicable |
||
Last Name |
First Name |
Title/Position |
|
|
|
Kallay |
Wynn |
Chairman/Chief Medical Officer/ Organization Development Committee Chair /Voting Member |
38% |
ACO Participant Representative |
Southeast Georgia Pediatrics |
McClure |
Jeremiah |
Spotlight Committee Chair/Voting Member |
3% |
Other |
MCC Internal Medicine, LLC |
Lane |
Carl |
Voting Member |
3% |
Medicare Beneficiary Representative |
N/A |
Moore, Jr. |
Malcolm S. |
Compliance Officer/Voting Member |
3% |
Other |
Eye Center of Central Georgia, PC |
Barry |
Stephen |
GPAC CEO/Voting Member |
3% |
Other |
N/A |
Steele |
Collyn |
Voting Member |
3% |
Other |
Eagles Landing Family Practice, Inc. |
Williamson |
Andy |
Voting Member |
3% |
Other |
Medical Center, LLP |
O'Neal |
Russell |
Voting Member |
3% |
Other |
Russell G. O'Neal, LLC |
Keating |
William |
Voting Member |
3% |
Other |
Dawsonville Family Medicine |
Broyles |
Tony |
Voting Member |
3% |
Other |
Internal Medicine Associates, PC |
Moore |
Helen-Louise |
Voting Member |
38% |
ACO Participant Representative |
Cornerstone Medical Assoc, LLC |
Key ACO clinical and administrative leadership:
ACO Executive |
Stephen Barry |
Medical Director |
Wynn Kallay, M.D. |
Compliance Officer |
Malcolm S. Moore, JR., M.D. |
Quality Assurance/Improvement Officer |
Wynn Kallay, M.D. |
Associated committees and committee leadership:
Committee Name |
Committee Leader Name and Position |
Organization Development |
Wynn Kallay, M.D./ Chairman |
Patient Engagement |
Wynn Kallay, M.D./Chairman |
Finance |
Steve Barry/Chairman |
Spotlight |
Jeremiah McClure, M.D./Chairman |
Quality |
Wynn Kallay, M.D. /Chairman |
Types of ACO participants, or combinations of participants, that formed the ACO:
· Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
Fourth Agreement Period
· Performance Year 2021, $3,452,231.10
Third Agreement Period
· Performance Year 2020, $3,392,388.00
Second Agreement Period
· Performance Year 2019, $0
· Performance Year 2018, $0
· Performance Year 2017, $0
First Agreement Period
· Performance Year 2016, $0
· Performance Year 2015, $0
· Performance Year 2014, $0
Shared Savings Distribution
Fourth Agreement Period
Performance Year 2021
· Proportion invested in infrastructure: 40%
· Proportion invested in redesigned care processes/resources: 20%
· Proportion of distribution to ACO participants: 40%
Third Agreement Period
Performance Year 2020
· Proportion invested in infrastructure: 40%
· Proportion invested in redesigned care processes/resources: 20%
· Proportion of distribution to ACO participants: 40%
Second Agreement Period
Performance Year 2019
· Proportion invested in infrastructure: N/A
· Proportion invested in redesigned care processes/resources: N/A
· Proportion of distribution to ACO participants: N/A
Performance Year 2018
· Proportion invested in infrastructure: N/A
· Proportion invested in redesigned care processes/resources: N/A
· Proportion of distribution to ACO participants: N/A
Performance Year 2017
· Proportion invested in infrastructure: N/A
· Proportion invested in redesigned care processes/resources: N/A
· Proportion of distribution to ACO participants: N/A
First Agreement Period
Performance Year 2016
· Proportion invested in infrastructure: N/A
· Proportion invested in redesigned care processes/resources: N/A
· Proportion of distribution to ACO participants: N/A
Performance Year 2015
· Proportion invested in infrastructure: N/A
· Proportion invested in redesigned care processes/resources: N/A
· Proportion of distribution to ACO participants: N/A
Performance Year 2014
· Proportion invested in infrastructure: N/A
· Proportion invested in redesigned care processes/resources: N/A
· Proportion of distribution to ACO participants: N/A
Quality Performance Results
2021 Quality Performance Results:
Measure # |
Measure Name |
Rate |
ACO Mean |
001 |
Diabetes: Hemoglobin A1c (HbA1c) Poor Control* |
6.64 |
12.46 |
134 |
Preventative Care and Screening: Screening for Depression and follow-up Plan |
74.09 |
74.38 |
236 |
Controlling High Blood Pressure |
72.22 |
74.87 |
318 |
Falls: Screening for Future Fall Risk |
85.09 |
87.03 |
110 |
Preventative Care and Screening: Influenza Immunization |
79.94 |
80.52 |
226 |
Preventative Care Screening: Tobacco Use: Screening Cessation Intervention |
82.61 |
80.97 |
113 |
Colorectal Cancer Screening |
78.49 |
73.63 |
112 |
Breast Cancer Screening |
79.40 |
75.11 |
438 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
87.88 |
84.24 |
479 |
Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups* |
0.1553 |
0.1540 |
MCC1 |
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)* |
32.10 |
33.99 |
For PY2021, measure #134, #438, and #370 do not have CMS Web Interface benchmarks and are not scored as a result
Please note, the Quality ID #:370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size
* A lower performance reate corresponds to higher quality
Measure ID |
Measure Name |
Rate |
ACO Mean |
CAHPS-1 |
Getting Timely Care, Appointments, and Information |
86.44 |
84.67 |
CAHPS-2 |
How Well Providers Communicate |
93.47 |
93.56 |
CAHPS-3 |
Patient's Raying of Provider |
92.62 |
92.19 |
CAHPS-4 |
Access to Specialists |
82.06 |
78.80 |
CAHPS-5 |
Health Promotion and Education |
62.54 |
61.61 |
CAHPS-6 |
Shared Decision Making |
63.02 |
60.89 |
CAHPS-7 |
Health Status and Functional Status |
68.81 |
71.78 |
CHAPS-8 |
Care Coordination |
86.26 |
85.66 |
CAHPS-9 |
Courteous and Helpful Office Staff |
92.45 |
91.88 |
CAHPS-11 |
Stewardship of Patient Resources |
29.07 |
24.71 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.
Payment Rule Waivers
· Waiver for Payment for Telehealth Services:
o Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
Georgia Physicians for Accountable Care (GPAC) participates in the Medicare Shared Savings Program (MSSP) and certain waivers are available through the MSSP. Specifically, GPAC has utilized the MSSP participation waivers in connection with the following programs and Waiver Protection is Sought under Interim Final Rule of Health and Human Services Office of Inspector General and Centers for Medicare and Medicaid Services for these arrangements.
(As published at 76 Fed. Reg. 67,992 (Nov. 2, 2011).)
Fraud and Abuse Waivers
ACO Participation Waiver
Laboratory Corporation of America Holdings (LabCorp)
Parties to arrangement: Georgia Physicians for Accountable Care, LLC, Laboratory Corporation of America Holdings (LabCorp) and all members of GPAC.
11/15/2016
GPAC has contracted with Laboratory Corporation of America Holdings (LabCorp) to assist in the implementation and on-going operation of care coordination for its Medicare members. The care coordination support will help GPAC facilitate its efforts to implement case management and care coordination of its MSSP attributed lives.
LabCorp’s support of care coordination for GPAC was reviewed by and received GPAC governing board approval and confirmation that such programs meet the purposes of the MSSP and thus qualify for participation waiver treatment under MSSP.
Magna Care Hospital Specialists
Parties to arrangement: Georgia Physicians for Accountable Care, LLC, Magna Care Hospital Specialists and all members of GPAC.
10/17/2017
GPAC has partnered with Magna Care Hospital Specialists to provide hospitalist services for GPAC providers. This partnership will allow for effective discharge planning and transition of care programs, in order to minimize and/or eliminate unnecessary readmissions.
GPAC and Magna Care Hospital Specialists partnership was reviewed by and received GPAC governing board approval and confirmation that such service meet the purposes of the MSSP and thus qualify for participation waiver treatment under MSSP.
Encompass Home Health and Hospice
Parties to arrangement: Georgia Physicians for Accountable Care, LLC, Encompass Home Health and Hospice and all members of GPAC.
08/15/2017
GPAC has partnered with Encompass Home Health and Hospice to provide home health and hospice services for GPAC providers. This partnership will allow for improved coordination of post acute care, monitoring of quality metrics and development of the initiatives to improve the delivery of home health and hospice services.
GPAC and Encompass Home Health and Hospice partnership was reviewed by and received GPAC governing board approval and confirmation that such service meet the purposes of the MSSP and thus qualify for participation waiver treatment under MSSP.